Artificial DNA can control release of active ingredients from drugs

A drug with three active ingredients that are released in sequence at specific times is under development by a team at the Technical University of Munich (TUM). What was once a pharmacologist's dream is now much closer to reality. With a combination of hydrogels and artificial DNA, nanoparticles can be released in sequence under conditions similar to those in the human body.